Financial Report: BASi

BASi

3Q Revenues: $8.5 million (+5%)

3Q Earnings: $0.4 million (+45%)

YTD Revenues: $25.0 million (+17%)

YTD Earnings: $1.2 million (loss of $2.4 million YTD10)

Comments: Service revenue accounted for $6.7 million in the quarter, up 12%. Product revenue was down 14% to $1.7 million. Anthony Chilton, president and chief executive officer, said, “Pricing is improving, although it still lags pre-recession levels, and the volume of studies and number of samples to assay have increased steadily for us so far this year. We also have experienced an increase in proposal opportunities and in new orders accepted, especially in our toxicology group.”